These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32260582)

  • 1. Metabolomic Studies of Lipid Storage Disorders, with Special Reference to Niemann-Pick Type C Disease: A Critical Review with Future Perspectives.
    Percival BC; Gibson M; Wilson PB; Platt FM; Grootveld M
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.
    Yañez MJ; Marín T; Balboa E; Klein AD; Alvarez AR; Zanlungo S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165875. PubMed ID: 32522631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
    Platt FM
    Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niemann-Pick type C disease: The atypical sphingolipidosis.
    Newton J; Milstien S; Spiegel S
    Adv Biol Regul; 2018 Dec; 70():82-88. PubMed ID: 30205942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiency.
    Maekawa M; Shimada M; Ohno K; Togawa M; Nittono H; Iida T; Hofmann AF; Goto J; Yamaguchi H; Mano N
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):576-87. PubMed ID: 25575700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.
    Probert F; Ruiz-Rodado V; Vruchte DT; Nicoli ER; Claridge TDW; Wassif CA; Farhat N; Porter FD; Platt FM; Grootveld M
    Sci Rep; 2017 Jul; 7(1):6320. PubMed ID: 28740230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry.
    Mashima R; Okuyama T; Ohira M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
    Pettazzoni M; Froissart R; Pagan C; Vanier MT; Ruet S; Latour P; Guffon N; Fouilhoux A; Germain DP; Levade T; Vianey-Saban C; Piraud M; Cheillan D
    PLoS One; 2017; 12(7):e0181700. PubMed ID: 28749998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune responses in the brain of sphingolipid lysosomal storage diseases.
    Vitner EB; Futerman AH; Platt N
    Biol Chem; 2015 Jun; 396(6-7):659-67. PubMed ID: 25720063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niemann-Pick type C disease: cellular pathology and pharmacotherapy.
    Wheeler S; Sillence DJ
    J Neurochem; 2020 Jun; 153(6):674-692. PubMed ID: 31608980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studies.
    Probert F; Ruiz-Rodado V; Zhang X; te Vruchte D; Claridge TD; Edgar M; Tocchio AZ; Lachmann RH; Platt FM; Grootveld M
    J Pharm Biomed Anal; 2016 Jan; 117():276-88. PubMed ID: 26397207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker analysis of Niemann-Pick disease type C using chromatography and mass spectrometry.
    Maekawa M; Iwahori A; Mano N
    J Pharm Biomed Anal; 2020 Nov; 191():113622. PubMed ID: 32998104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease.
    Schultz ML; Krus KL; Lieberman AP
    Brain Res; 2016 Oct; 1649(Pt B):181-188. PubMed ID: 27026653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
    Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
    FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
    Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature.
    Voorink-Moret M; Goorden SMI; van Kuilenburg ABP; Wijburg FA; Ghauharali-van der Vlugt JMM; Beers-Stet FS; Zoetekouw A; Kulik W; Hollak CEM; Vaz FM
    Mol Genet Metab; 2018 Feb; 123(2):76-84. PubMed ID: 29290526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
    Paron F; Dardis A; Buratti E
    J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.
    Vanier MT; Gissen P; Bauer P; Coll MJ; Burlina A; Hendriksz CJ; Latour P; Goizet C; Welford RW; Marquardt T; Kolb SA
    Mol Genet Metab; 2016 Aug; 118(4):244-54. PubMed ID: 27339554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases.
    Toledano-Zaragoza A; Ledesma MD
    Neuropharmacology; 2020 Jul; 171():107851. PubMed ID: 31734384
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.